"Rationalization of therapy of multiple myeloma"@en . "0"^^ . . " incidence" . . "2015-01-22+01:00"^^ . "1"^^ . "4"^^ . . . " overall survival" . "Currently, it is obvious that multiple myeloma is not a single disease but rather a set of several subgroups with defined prognostic importance and it is obvious that due to new efficient drugs, MM is being changed into a chronic tumor disease with the necessity of individualization of treatment and specification of optimal long-term treatment strategy. Investigators of this project will collect, digitalize and analyze data, characterize prognostic factors and analyze the results of treatment of patients with MM treated by individual protocols while pharmaco-economic demands of new treatments are taken into consideration."@en . "47"^^ . . "47"^^ . "multiple myeloma; prognostic factors; optimal therapy; incidence; free survival; overall survival; autologous transplantation"@en . . "multiple myeloma" . "2014-12-31+01:00"^^ . . "http://www.isvav.cz/projectDetail.do?rowId=NT12215"^^ . . . "NT12215" . . " prognostic factors" . " optimal therapy" . . . "2011-06-01+02:00"^^ . . " free survival" . . . . . "Racionalizace l\u00E9\u010Dby mnoho\u010Detn\u00E9ho myelomu" . "2013-03-26+01:00"^^ . "V dne\u0161n\u00ED dob\u011B je zjevn\u00E9, \u017Ee mnoho\u010Detn\u00FD myelom nen\u00ED jednotn\u00FDm onemocn\u011Bn\u00EDm, ale zahrnuje n\u011Bkolik subjednotek s definovan\u00FDm prognostick\u00FDm v\u00FDznamem a je zjevn\u00E9, \u017Ee d\u00EDky \u0159ad\u011B nov\u00FDch \u00FA\u010Dinn\u00FDch l\u00E9k\u016F se mnoho\u010Detn\u00FD myelom m\u011Bn\u00ED v chronick\u00E9 n\u00E1dorov\u00E9 onemocn\u011Bn\u00ED s nutnost\u00ED individualizace l\u00E9\u010Dby a stanoven\u00ED optim\u00E1ln\u00ED dlouhodob\u00E9 l\u00E9\u010Debn\u00E9 strategie. \u0158e\u0161itel\u00E9 navrhovan\u00E9ho projektu budou prov\u00E1d\u011Bt sb\u011Br, digitalizaci a anal\u00FDzu dat, charakterizuj\u00EDc\u00EDch prognostick\u00E9 faktory a analyzovat v\u00FDsledky l\u00E9\u010Dby nemocn\u00FDch s mnoho\u010Detn\u00FDm myelomem v obdob\u00ED diagn\u00F3zy a ve f\u00E1zi progrese/relapsu nemoci l\u00E9\u010Den\u00FDch jednotn\u00FDmi protokoly s p\u0159ihl\u00E9dnut\u00EDm k farmakoekonomick\u00E9 n\u00E1ro\u010Dnosti nov\u00FDch l\u00E9\u010Debn\u00FDch postup\u016F." .